Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169

Showing 26-50 of 169 citing articles:

The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy
Faheem Shehjar, Daniyah A. Almarghalani, Reetika Mahajan, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 188-188
Open Access | Times Cited: 6
From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer’s and Parkinson’s diseases
Debia Wakhloo, Sameehan Mahajani, Jane Oberhauser, et al.
Neural Regeneration Research (2022) Vol. 17, Iss. 12, pp. 2606-2606
Open Access | Times Cited: 26
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5
The development and benefits of metformin in various diseases
Ying Dong, Yingbei Qi, Haowen Jiang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 388-431
Closed Access | Times Cited: 12
Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
Yue Wu, Zhongting Zhao, Naidi Yang, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 153-153
Open Access | Times Cited: 11
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease
Ignacio Serrano, Marta Pedreño, Julia Castillo-González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 694-694
Open Access | Times Cited: 4
Acupuncture activates IRE1/XBP1 endoplasmic reticulum stress pathway in Parkinson's disease model rats
Zhifang Wang, Menglin Kou, Qiyue Deng, et al.
Behavioural Brain Research (2024) Vol. 462, pp. 114871-114871
Closed Access | Times Cited: 4
Causal Association Between Cerebrospinal Fluid Metabolites and Parkinson's Disease: A Two-Sample Bidirectional Mendelian Randomization Study
Jing Liao, Liangyan Jiang, Yiliu Qin, et al.
Behavioural Brain Research (2025), pp. 115426-115426
Closed Access
In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders
Stephen Tunmise Akanbi, Joshua Ayodele Yusuf, Thompson Oluwaferanmi Ayandele, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Synthesis and Study of Anticonvulsant, Anti-Ischemic, and Antihypoxic Activity of NMDA and AMPA Dicationic Adamantane-Containing Open Channel Blockers In Vitro and In Vivo
В. Е. Гмиро, Arseniy S. Zhigulin
Pharmaceutical Chemistry Journal (2025)
Closed Access
Stem-leaf saponins of Panax notoginseng attenuate experimental Parkinson's disease progression in mice by inhibiting microglia-mediated neuroinflammation via P2Y2R/PI3K/AKT/NFκB signaling pathway
Hui Wu, Chenyang Ni, Yu Zhang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 43-53
Closed Access
Assessing Eligibility for Apomorphine Therapy in Parkinson's Disease: The Telemonitoring Potential
Alagaratnam Niruban, Václav Dostál, Abigail Mutimer, et al.
Movement Disorders Clinical Practice (2025)
Closed Access
Nature's Neuroprotector: Honokiol and Its Promise for Alzheimer's and Parkinson's
Ahsas Goyal, Anshika Kumari, Aanchal Verma, et al.
Brain Disorders (2025), pp. 100208-100208
Open Access
Extracellular Vesicles for Disease Treatment
Fangyan Wang, Jiayin Feng, Anqi Jin, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3303-3337
Open Access
Cell-penetrating proteins and peptides as a promising theragnostic agent for neurodegenerative disorder
Bhaskaranand Pancholi, Mayank Kumar Choudhary, Manoj Kumar, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106816-106816
Open Access
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk
Stefano Caproni, Alessio Di Fonzo, Carlo Colosimo
Parkinson s Disease (2025) Vol. 2025, Iss. 1
Open Access
Demographic and Clinical Characteristics in Different Motor Subtypes of Parkinson’s Disease: How Well Do the Findings Fit Within the Framework of Existing Hypotheses?
Timotej Petrijan, Marija Menih
Neurology International (2025) Vol. 17, Iss. 4, pp. 51-51
Open Access
Mitochondrial Bioenergetics in Different Pathophysiological Conditions 4.0
Daniela Valenti, Anna Atlante
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3396-3396
Open Access
Patterns of cerebellar cortex hypermetabolism on motor and cognitive functions in PD
Wenhua Ren, Bin Chen, Jiu-Qin He, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
A Parkinson’s Disease Gait Identification Model Based on Attention Mechanism and Long Short-Term Memory Network
Jianxian Zhang, Xianghan Zheng, Huan Wang, et al.
Pervasive Computing Technologies for Healthcare (2025), pp. 251-263
Closed Access
Real-world performance evaluation of a telemonitoring system for Parkinson’s disease symptom assessment
Eleni Kosmidi, Foivos S. Kanellos, Georgia Xiromerisiou, et al.
Journal of Clinical Neuroscience (2025) Vol. 136, pp. 111285-111285
Open Access
Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts
Liwei Wang, Ping Yang, Chao Yang, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 7, pp. 1283-1296
Closed Access | Times Cited: 18
Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
Yulia Aleksandrova, Kirill Chaprov, Alexandra V. Podturkina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5842-5842
Open Access | Times Cited: 10
Identification of necroptosis-related genes in Parkinson’s disease by integrated bioinformatics analysis and experimental validation
Lei Cheng, Zhong-Yan Zhou, Wenting Shi, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Pterostilbene as a Therapeutic Alternative for Central Nervous System Disorders: A Review of the Current Status and Perspectives
Xin Qu, Lijuan Zhang, Lin Wang
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 40, pp. 14432-14457
Closed Access | Times Cited: 10

Scroll to top